Presentations

CIO 2020 Panel Discussion: Session 1, Discussion 3

CIO Course Directors and Faculty

Presented at Symposium on Clinical Interventional Oncology 2020

CIO Live Discussion - Liver Therapies Panel #3 from HMP on Vimeo.

CIO course directors and faculty answer audience questions submitted during the following presentation:

Data You Should Know: Most Influential Publications Over the Last Year

Ziv J. Haskal, MD, Professor/ Fellowship Director, University of Virginia School of Medicine

About Us

Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a monthly peer-reviewed online journal that educates readers on the latest advancements in endovascular treatment strategies.

Learn more about ISET and AMP and register for the events here:

Subscribe Now!

Vascular Disease Management Newsletter

News

LAA Occluders

Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke

11/03/2026

Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...

Late-breaking one-year...

11/03/2026

Vascular Disease Management

Intravascular Lithotripsy

Abbott's TECTONIC Clinical Trial Demonstrates Strong 30-day Outcomes and High Procedural Success for Its Investigational SonicForce™ Coronary Intravascular Lithotripsy System

11/03/2026

Vascular Disease Management

Stroke Clinical Trials

Could A Drug for Leg Cramps Prevent a Second, Deadlier Stroke?

10/30/2026

The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).

The trial is funded by the...

10/30/2026

Cath Lab Digest

Radiation Safety

Rampart Launches Vanguard™ at TCT 2026, Extending Total-Body Radiation Protection to Interventional Imagers

10/29/2026

Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.

Purpose-built head-of-table...

10/29/2026

Vascular Disease Management

Peripheral Arterial Bleeds

Instylla's Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds

10/29/2026

Vascular Disease Management

Large-Bore Closure

Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System

10/27/2026

The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...

The PerQseal Elite system...

10/27/2026

Cath Lab Digest

FDA Approvals

Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)

10/20/2026

ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...

ALAMEDA, Calif. -- Penumbra,...

10/20/2026

Cath Lab Digest

Pulmonary Embolism

Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients

10/19/2026

The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...

The Vertex system leverages the...

10/19/2026

Cath Lab Digest

Endovascular Aortic Repair

FDA Approves GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis for Expanded use in FEVAR and BEVAR

10/15/2026

Vascular Disease Management

Deep Learning

Deep Learning Model Predicts Hepatocellular Carcinoma Progression Following Transarterial Chemoembolization

10/09/2026

Laura Simson, MA

A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.

A prediction model combining...

10/09/2026

Vascular Disease Management

CIO 2020 Panel Discussion: Session 1, Discussion 3

About Us

Subscribe Now!

News

HMP Global Products

Events